ClariVest Asset Management’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $16.9K | Hold |
895
| – | – | ﹤0.01% | 384 |
|
|
2024
Q2 | $16.9K | Buy |
895
+99
| +12% | +$1.69K | ﹤0.01% | 384 |
|
|
2024
Q1 | $12.9K | Buy |
796
+74
| +10% | +$1.08K | ﹤0.01% | 400 |
|
|
2023
Q4 | $9.14K | Hold |
722
| – | – | ﹤0.01% | 413 |
|
|
2023
Q3 | $10K | Buy |
722
+423
| +141% | +$6.53K | ﹤0.01% | 399 |
|
|
2023
Q2 | $5K | Hold |
299
| – | – | ﹤0.01% | 437 |
|
|
2023
Q1 | $4K | Sell |
299
-13
| -4% | -$191 | ﹤0.01% | 510 |
|
|
2022
Q4 | $4K | Hold |
312
| – | – | ﹤0.01% | 504 |
|
|
2022
Q3 | $4K | Hold |
312
| – | – | ﹤0.01% | 492 |
|
|
2022
Q2 | $4K | Sell |
312
-37,649
| -99% | -$483K | ﹤0.01% | 512 |
|
|
2022
Q1 | $491K | Sell |
37,961
-283,381
| -88% | -$3.74M | 0.02% | 386 |
|
|
2021
Q4 | $5.09M | Sell |
321,342
-25,899
| -7% | -$442K | 0.16% | 125 |
|
|
2021
Q3 | $6.77M | Sell |
347,241
-69,990
| -17% | -$1.39M | 0.22% | 95 |
|
|
2021
Q2 | $9.5M | Buy |
417,231
+9,256
| +2% | +$192K | 0.32% | 67 |
|
|
2021
Q1 | $7.5M | Buy |
407,975
+53,446
| +15% | +$876K | 0.27% | 77 |
|
|
2020
Q4 | $5.29M | Sell |
354,529
-139,070
| -28% | -$1.82M | 0.18% | 102 |
|
|
2020
Q3 | $5.54M | Buy |
493,599
+15,709
| +3% | +$155K | 0.18% | 103 |
|
|
2020
Q2 | $3.79M | Buy |
477,890
+10,081
| +2% | +$83.5K | 0.1% | 144 |
|
|
2020
Q1 | $3.78M | Buy |
467,809
+126,080
| +37% | +$1.5M | 0.11% | 119 |
|
|
2019
Q4 | $4.3M | Buy |
341,729
+188,902
| +124% | +$2.03M | 0.1% | 159 |
|
|
2019
Q3 | $1.37M | Sell |
152,827
-742
| -0.5% | -$6.49K | 0.03% | 308 |
|
|
2019
Q2 | $1.31M | Sell |
153,569
-371
| -0.2% | -$2.93K | 0.03% | 287 |
|
|
2019
Q1 | $1.17M | Sell |
153,940
-1,114
| -0.7% | -$8.96K | 0.02% | 380 |
|
|
2018
Q4 | $1.28M | Sell |
155,054
-2,970
| -2% | -$28.4K | 0.03% | 365 |
|
|
2018
Q3 | $1.57M | Hold |
158,024
| – | – | 0.03% | 362 |
|
|
2018
Q2 | $1.55M | Sell |
158,024
-27,097
| -15% | -$266K | 0.03% | 377 |
|
|
2018
Q1 | $1.72M | Buy |
+185,121
| New | +$1.76M | 0.03% | 360 |
|
|
2016
Q4 | – | Sell |
-120,872
| Closed | -$879K | – | 718 |
|
|
2016
Q3 | $879K | Sell |
120,872
-639,938
| -84% | -$4.07M | 0.03% | 321 |
|
|
2016
Q2 | $4.46M | Buy |
760,810
+466,042
| +158% | +$3.09M | 0.13% | 105 |
|
|
2016
Q1 | $1.88M | Buy |
294,768
+11,784
| +4% | +$63.2K | 0.06% | 204 |
|
|
2015
Q4 | $1.82M | Buy |
282,984
+47,365
| +20% | +$296K | 0.05% | 206 |
|
|
2015
Q3 | $1.37M | Sell |
235,619
-5,383
| -2% | -$39.9K | 0.04% | 228 |
|
|
2015
Q2 | $2.1M | Sell |
241,002
-373
| -0.2% | -$3.13K | 0.06% | 195 |
|
|
2015
Q1 | $1.93M | Sell |
241,375
-3,134
| -1% | -$23.4K | 0.06% | 197 |
|
|
2014
Q4 | $1.9M | Sell |
244,509
-64,205
| -21% | -$468K | 0.07% | 166 |
|
|
2014
Q3 | $2M | Sell |
308,714
-95
| -0% | -$734 | 0.07% | 178 |
|
|
2014
Q2 | $2.59M | Buy |
+308,809
| New | +$2.39M | 0.1% | 136 |
|
Other funds holding SEM
CCM
ClariVest Asset Management's SEM Position: Q3 2024 in Review
ClariVest Asset Management held its Select Medical (SEM) position steady in Q3 2024 at 895 shares worth $16.9K. The position accounts for ﹤0.01% of the portfolio, ranked #384.
ClariVest Asset Management first reported a position in SEM in Q2 2014 and has held it in 37 quarters since. The position peaked at $9.5M in Q2 2021. 286 funds tracked by Wall St. Rank hold SEM as of Q3 2024.
- ClariVest Asset Management held 895 shares of Select Medical worth $16.9K as of Q3 2024.
- ClariVest Asset Management left its Select Medical share count unchanged in Q3 2024.
- Select Medical made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #384 holding.
- ClariVest Asset Management first reported a position in Select Medical in Q2 2014 and has held it in 37 quarters since.
- ClariVest Asset Management's Select Medical position peaked at $9.5M in Q2 2021.
- 286 funds tracked by Wall St. Rank held Select Medical as of Q3 2024.
Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.